Forwarded from a friend:

Canola oil linked to worsened memory and learning ability in Alzheimer's
https://www.sciencedaily.com/releases/2017/12/171207141624.htm 
<https://www.sciencedaily.com/releases/2017/12/171207141624.htm>
Date: December 7, 2017
Source: Temple University Health System
Summary: Canola oil is one of the most widely consumed vegetable oils, yet 
little is known about its health effects. Now, a study links canola oil 
consumption in the diet with worsened memory, worsened learning ability and 
weight gain in mice which model Alzheimer's disease. It's the first study to 
suggest that canola oil is more harmful than healthful for the brain.


Canola oil is one of the most widely consumed vegetable oils in the world, yet 
surprisingly little is known about its effects on health. Now, a new study 
published online December 7 in the journal Scientific Reports by researchers at 
the Lewis Katz School of Medicine at Temple University (LKSOM) associates the 
consumption of canola oil in the diet with worsened memory, worsened learning 
ability and weight gain in mice which model Alzheimer's disease. The study is 
the first to suggest that canola oil is more harmful than healthful for the 
brain.

"Canola oil is appealing because it is less expensive than other vegetable 
oils, and it is advertised as being healthy," explained Domenico Praticò, MD, 
Professor in the Departments of Pharmacology and Microbiology and Director of 
the Alzheimer's Center at LKSOM, as well as senior investigator on the study. 
"Very few studies, however, have examined that claim, especially in terms of 
the brain.”

Curious about how canola oil affects brain function, Dr. Praticò and Elisabetta 
Lauretti, a graduate student in Dr. Pratico's laboratory at LKSOM and co-author 
on the new study, focused their work on memory impairment and the formation of 
amyloid plaques and neurofibrillary tangles in an Alzheimer's disease mouse 
model. Amyloid plaques and phosphorylated tau, which is responsible for the 
formation of tau neurofibrillary tangles, contribute to neuronal dysfunction 
and degeneration and memory loss in Alzheimer's disease. The animal model was 
designed to recapitulate Alzheimer's in humans, progressing from an 
asymptomatic phase in early life to full-blown disease in aged animals.

Dr. Praticò and Lauretti had previously used the same mouse model in an 
investigation of olive oil, the results of which were published earlier in 
2017. In that study, they found that Alzheimer mice fed a diet enriched with 
extra-virgin olive oil had reduced levels of amyloid plaques and phosphorylated 
tau and experienced memory improvement. For their latest work, they wanted to 
determine whether canola oil is similarly beneficial for the brain.

The researchers started by dividing the mice into two groups at six months of 
age, before the animals developed signs of Alzheimer's disease. One group was 
fed a normal diet, while the other was fed a diet supplemented with the 
equivalent of about two tablespoons of canola oil daily.
The researchers then assessed the animals at 12 months. One of the first 
differences observed was in body weight -- animals on the canola oil-enriched 
diet weighed significantly more than mice on the regular diet. Maze tests to 
assess working memory, short-term memory, and learning ability uncovered 
additional differences. Most significantly, mice that had consumed canola oil 
over a period of six months suffered impairments in working memory.

Examination of brain tissue from the two groups of mice revealed that canola 
oil-treated animals had greatly reduced levels of amyloid beta 1-40. Amyloid 
beta 1-40 is the more soluble form of the amyloid beta proteins. It generally 
is considered to serve a beneficial role in the brain and acts as a buffer for 
the more harmful insoluble form, amyloid beta 1-42.

As a result of decreased amyloid beta 1-40, animals on the canola oil diet 
further showed increased formation of amyloid plaques in the brain, with 
neurons engulfed in amyloid beta 1-42. The damage was accompanied by a 
significant decrease in the number of contacts between neurons, indicative of 
extensive synapse injury. Synapses, the areas where neurons come into contact 
with one another, play a central role in memory formation and retrieval.

"Amyloid beta 1-40 neutralizes the actions of amyloid 1-42, which means that a 
decrease in 1-40, like the one observed in our study, leaves 1-42 unchecked," 
Dr. Praticò explained. "In our model, this change in ratio resulted in 
considerable neuronal damage, decreased neural contacts, and memory impairment.”

The findings suggest that long-term consumption of canola oil is not beneficial 
to brain health. Even though canola oil is a vegetable oil, we need to be 
careful before we say that it is healthy," Dr. Praticò said. "Based on the 
evidence from this study, canola oil should not be thought of as being 
equivalent to oils with proven health benefits.”

The next step is to carry out a study of shorter duration to determine the 
minimum extent of exposure necessary to produce observable changes in the ratio 
of amyloid beta 1-42 to 1-40 in the brain and alter synapse connections. A 
longer study may be warranted in order to determine whether canola oil also 
eventually impacts tau phosphorylation, since no effects on tau were observed 
over the six-month exposure period.

"We also want to know whether the negative effects of canola oil are specific 
for Alzheimer's disease," Dr. Praticò added. "There is a chance that the 
consumption of canola oil could also affect the onset and course of other 
neurodegenerative diseases or other forms of dementia."

The research was funded in part by a grant from the Wanda Simone Endowment for 
Neuroscience.
Story Source:
Materials provided by Temple University Health System 
<http://www.templehealth.org/>. Note: Content may be edited for style and 
length.
Journal Reference:
Elisabetta Lauretti, Domenico Pratic&#2013265922;. Effect of canola oil 
consumption on memory, synapse and neuropathology in the triple transgenic 
mouse model of Alzheimer’s disease. Scientific Reports, 2017; 7 (1) DOI: 
10.1038/s41598-017-17373-3 <http://dx.doi.org/10.1038/s41598-017-17373-3>

Reply via email to